
BeOne continues to grow at a rapid pace with challenging and exciting opportunities for experienced professionals. When considering candidates, we look for scientific and business professionals who are highly motivated, collaborative, and most importantly, share our passionate interest in fighting cancer.
Internship program dates: June 8 - August 21, 2026
Education Required: Graduação em andamento nos cursos de Administração de Empresas, Economia, Engenharia, Farcácia ou áreas correlatas, com vínculo estudantil ativo durante todo o estágio.
General Description/Scope of Responsibilities (Internship):
Acesso ao Mercado atua na interface entre a indústria farmacêutica, o sistema de saúde e os diferentes stakeholders (públicos e privados), com o objetivo de garantir que os pacientes tenham acesso sustentável e ágil a terapias inovadoras, como as oncológicas. A área envolve análise de cenário regulatório e econômico, definição de estratégias de precificação e reembolso, negociação com operadoras e órgãos públicos, além de geração de evidências que sustentem o valor clínico e econômico dos medicamentos.
Essential Functions of the Internship:
Computer Skills:
Other Qualifications:
Organização, planejamento, proatividade, atenção a detalhes e comunicação escrita e oral claras.
Inglês avançado. Espanhol ou outro idioma como diferencial.
Travel: 0% of time
Pay Rates:
Bachelors: $15/hour BRL
Masters: $16.50/hour BRL
Global Competencies
When we exhibit our values of Patients First, Driving Excellence, Bold Ingenuity, and Collaborative Spirit, through our twelve global competencies below, we help get more affordable medicines to more patients around the world.
We are proud to be an equal opportunity employer. BeOne does not discriminate on the basis of race, religion, color, sex, gender identity, sexual orientation, age, disability, national origin, veteran status or any other basis covered by appropriate law. All employment is decided on the basis of qualifications, merit, and business need.

Effective March 17, 2025, The U.S. subsidiary of BeiGene, Ltd. has changed its name to BeOne Medicines USA, Inc. This change comes ahead of our anticipated global rebranding to BeOne Medicines Ltd. and redomiciliation to Switzerland, pending shareholder approval. The new name reflects our commitment to develop innovative medicines and partner with the global community to help as many patients with cancer as possible.
To learn more about BeOne Medicines, please follow our new LinkedIn profile @BeOne Medicines.